BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17130631)

  • 1. Perceptions of industry responsibility and tobacco control policy by US tobacco company executives in trial testimony.
    Chaiton M; Ferrence R; LeGresley E
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv98-106. PubMed ID: 17130631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tobacco Deposition and Trial Testimony Archive (DATTA) project: origins, aims, and methods.
    Davis RM; Douglas CE; Beasley JK
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv4-8. PubMed ID: 17130623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tobacco advertising and promotion: themes employed in litigation by tobacco industry witnesses.
    Goldberg ME; Davis RM; O'Keefe AM
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv54-67. PubMed ID: 17130625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Stay away from them until you're old enough to make a decision": tobacco company testimony about youth smoking initiation.
    Wakefield M; McLeod K; Perry CL
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv44-53. PubMed ID: 17130624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco industry use of corporate social responsibility tactics as a sword and a shield on secondhand smoke issues.
    Friedman LC
    J Law Med Ethics; 2009; 37(4):819-27. PubMed ID: 20122118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential reduced exposure products (PREPs) in industry trial testimony.
    Wayne GF
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv90-7. PubMed ID: 17130630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the health belief model helps the tobacco industry: individuals, choice, and "information".
    Balbach ED; Smith EA; Malone RE
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv37-43. PubMed ID: 17130622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.
    Douglas CE; Davis RM; Beasley JK
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv9-16. PubMed ID: 17130629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A grim contradiction: the practice and consequences of corporate social responsibility by British American Tobacco in Malaysia.
    Barraclough S; Morrow M
    Soc Sci Med; 2008 Apr; 66(8):1784-96. PubMed ID: 18304713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.
    Milberger S; Davis RM; Douglas CE; Beasley JK; Burns D; Houston T; Shopland D
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv17-26. PubMed ID: 17130620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corporate social responsibility and the tobacco industry: hope or hype?
    Hirschhorn N
    Tob Control; 2004 Dec; 13(4):447-53. PubMed ID: 15564636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
    Muggli ME; Hurt RD; Becker LB
    Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco industry consumer research on socially acceptable cigarettes.
    Ling PM; Glantz SA
    Tob Control; 2005 Oct; 14(5):e3. PubMed ID: 16183968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Using information to shape perception": tobacco industry documents study of the evolution of Corporate Affairs in the Miller Brewing Company.
    McCambridge J; Garry J; Kypri K; Hastings G
    Global Health; 2022 May; 18(1):52. PubMed ID: 35597943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.
    Tong EK; Glantz SA
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Accommodating" smoke-free policies: tobacco industry's Courtesy of Choice programme in Latin America.
    SebriƩ EM; Glantz SA
    Tob Control; 2007 Oct; 16(5):e6. PubMed ID: 17897975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding Philip Morris's pursuit of US government regulation of tobacco.
    McDaniel PA; Malone RE
    Tob Control; 2005 Jun; 14(3):193-200. PubMed ID: 15923470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarettes become a dangerous product: tobacco in the rearview mirror, 1952-1965.
    Dorfman L; Cheyne A; Gottlieb MA; Mejia P; Nixon L; Friedman LC; Daynard RA
    Am J Public Health; 2014 Jan; 104(1):37-46. PubMed ID: 24228675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Living Tomorrow Project: how Philip Morris has used a Belgian tourist attraction to promote ventilation approaches to the control of second hand smoke.
    Pilkington P; Gilmore AB
    Tob Control; 2004 Dec; 13(4):375-8. PubMed ID: 15564621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.